Literature DB >> 11499357

Molecular and cellular events associated with ischemia/reperfusion injury.

I Laskowski1, J Pratschke, M J Wilhelm, M Gasser, N L Tilney.   

Abstract

I/R is an important non-specific, antigen independent event, which significantly influences the outcome of transplanted organs. Increasing graft immunogenicity and host alloresponsiveness inflicts additional deleterious effects. Ischemia has also been associated with donor conditions such as brain death and the non-heart-beating donor. As an event surrounding organ procurement, preservation and revascularization occurring early in the transplant process, it initiates a cascade of molecular and cellular events which trigger the release of proinflammatory mediators and attraction of various cell types infiltrating the tissues. This inflammatory event influences both acute functional and structural changes in the organ which contributes to reduced graft survival. Eventually, attenuation of I/R by strategies targeting various mediators and cell populations at different levels of the inflammatory cascade may constitute a means to improve both short and long-term success of solid organ grafts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11499357

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  15 in total

Review 1.  Islet transplantation in the twenty-first century.

Authors:  Frank T Thomas; Anne Hutchings; Juan Contreras; Jianguo Wu; Xiao Ling Jiang; Devin Eckhoff; Judith M Thomas
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.

Authors:  Tarek El-Sawy; Masayoshi Miura; Robert Fairchild
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

3.  TFF3 modulates NF-{kappa}B and a novel negative regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}.

Authors:  Ya-Qin Zhu; Xiao-Di Tan
Journal:  Am J Physiol Cell Physiol       Date:  2005-07-13       Impact factor: 4.249

4.  Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation.

Authors:  Danh T Tran; Scott Esckilsen; Jennifer Mulligan; Shikhar Mehrotra; Carl Atkinson; Satish N Nadig
Journal:  Transplantation       Date:  2018-06       Impact factor: 4.939

5.  Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys.

Authors:  Naohiko Shimoda; Nobuyuki Fukazawa; Katsuya Nonomura; Robert L Fairchild
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

6.  Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats.

Authors:  Jin-Lian Chen; Tong Zhou; Wei-Xiong Chen; Jin-Shui Zhu; Ni-Wei Chen; Ming-Jun Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

7.  Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy.

Authors:  Julian R Pratt; Miriam E Jones; Jun Dong; Wuding Zhou; Paramit Chowdhury; Richard A G Smith; Steven H Sacks
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant.

Authors:  E Sharif-Paghaleh; M L Yap; L L Meader; K Chuamsaamarkkee; F Kampmeier; A Badar; R A Smith; S Sacks; G E Mullen
Journal:  Am J Transplant       Date:  2015-04-23       Impact factor: 8.086

9.  The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.

Authors:  Fang-Ting Chen; Chung-May Yang; Chang-Hao Yang
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

Review 10.  Neutrophil 'connectivity': key to neutrophil-mediated tissue injury?

Authors:  Salahaddin Mahmudi-Azer; Stephan F van Eeden
Journal:  Crit Care       Date:  2003-02-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.